NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

It’s total nonsense. Plus then he goes on to say CRL should buy Advent. But Advent was spun off from CRL, from Cognate. It’s total nonsense.

NWBO will likely contract with CRL, but I expect that will only be a temporary arrangement for the first few years. NWBO has Flaskworks and I expect they will eventually build smaller facilities around the world with the help of Advent, as facilities manager, which is also small and therefore more flexible and adaptive. Plus you don’t have the likelihood that Advent wants to steal the technology which will be a core patent protection element of NWBO’s competitive advantage in this space. But more importantly, they likely won’t even need a CDMO when Flaskworks is fully integrated. But the value of that operational history and experience probably simply is invaluable and Advent will have a huge leg up on CRL which has never produced such a product commercially. Ever.